Targeting NEDD8-activating enzyme abrogates NF-kappaB and induces DNA damage and checkpoint activation in chronic lymphocytic leukemia B-cells

被引：0
|
作者：
Paiva, Cody
Godbersen, Claire
Berger, Allison
Brown, Jennifer
Danilov, Alexey
机构：
[1] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA
[2] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
[3] Takeda Pharmaceut Co Ltd, Cambridge, MA USA
来源：
LEUKEMIA & LYMPHOMA | 2015年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
114
引用
收藏
页码：95 / 96
页数：2
相关论文
共 17 条
  • [1] Targeting Microenvironment-Mediated NFκb Activation With MLN4924, An Inhibitor Of The Nedd8-Activating Enzyme, In Chronic Lymphocytic Leukemia B Cells
    Godbersen, Claire
    Eastman, Alan
    Brown, Jennifer R.
    Danilov, Alexey V.
    BLOOD, 2013, 122 (21)
  • [2] Targeting Nedd8 Activating Enzyme Induces DNA Damage and Cell Cycle Arrest and Sensitizes Chronic Lymphocytic Leukemia (CLL) B-Cells to Alkylating Agents
    Godbersen, Claire
    Paiva, Cody
    Berger, Allison J.
    Brown, Jennifer R.
    Danilov, Alexey V.
    BLOOD, 2014, 124 (21)
  • [3] The Nedd8-Activating Enzyme Inhibitor MLN4924 Thwarts Microenvironment-Driven NF-κB Activation and Induces Apoptosis in Chronic Lymphocytic Leukemia B Cells
    Godbersen, J. Claire
    Humphries, Leigh Ann
    Danilova, Olga V.
    Kebbekus, Peter E.
    Brown, Jennifer R.
    Eastman, Alan
    Danilov, Alexey V.
    CLINICAL CANCER RESEARCH, 2014, 20 (06) : 1576 - 1589
  • [4] Targeting neddylation induces DNA damage and checkpoint activation and sensitizes chronic lymphocytic leukemia B cells to alkylating agents
    C Paiva
    J C Godbersen
    A Berger
    J R Brown
    A V Danilov
    Cell Death & Disease, 2015, 6 : e1807 - e1807
  • [5] Targeting neddylation induces DNA damage and checkpoint activation and sensitizes chronic lymphocytic leukemia B cells to alkylating agents
    Paiva, C.
    Godbersen, J. C.
    Berger, A.
    Brown, J. R.
    Danilov, A. V.
    CELL DEATH & DISEASE, 2015, 6 : e1807 - e1807
  • [6] Immunomodulatory effects of pevonedistat, a NEDD8-activating enzyme inhibitor, in chronic lymphocytic leukemia-derived T cells
    Scott Best
    Vi Lam
    Tingting Liu
    Nur Bruss
    Adam Kittai
    Olga V. Danilova
    Susan Murray
    Allison Berger
    Nathan D. Pennock
    Evan F. Lind
    Alexey V. Danilov
    Leukemia, 2021, 35 : 156 - 168
  • [7] Immunomodulatory effects of pevonedistat, a NEDD8-activating enzyme inhibitor, in chronic lymphocytic leukemia-derived T cells
    Best, Scott
    Lam, Vi
    Liu, Tingting
    Bruss, Nur
    Kittai, Adam
    Danilova, Olga V.
    Murray, Susan
    Berger, Allison
    Pennock, Nathan D.
    Lind, Evan F.
    Danilov, Alexey V.
    LEUKEMIA, 2021, 35 (01) : 156 - 168
  • [8] Immunomodulatory Effects of Pevonedistat, a NEDD8-Activating Enzyme (NAE) Inhibitor, in Chronic Lymphocytic Leukemia (CLL)
    Best, Scott R.
    Kittai, Adam
    Rowland, Taylor
    Bruss, Nur
    Spurgeon, Stephen E.
    Berger, Allison
    Moran, Amy
    Danilov, Alexey V.
    BLOOD, 2018, 132
  • [9] The Nedd8-Activating Enzyme Inhibitor MLN4924 Thwarts Microenvironment-Driven NF-κB Activation and Induces Apoptosis in Chronic Lymphocytic Leukemia B Cells (vol 20, pg 1576, 2014)
    Godbersen, J.
    Humphries, L.
    Danilova, O., V
    Kebbekus, P. E.
    Brown, J. R.
    Eastman, A.
    CLINICAL CANCER RESEARCH, 2016, 22 (16) : 4274 - 4274
  • [10] The NEDD8-activating enzyme inhibitor MLN4924 induces DNA damage in Ph plus leukemia and sensitizes for ABL kinase inhibitors
    Bahjat, Mahnoush
    de Wilde, Guus
    van Dam, Tijmen
    Maas, Chiel
    Bloedjes, Timon
    Bende, Richard J.
    van Noesel, Carel J. M.
    Luijks, Dieuwertje M.
    Elderin, Eric
    Kersten, Marie Jose
    Guikema, Jeroen E. J.
    CELL CYCLE, 2019, 18 (18) : 2307 - 2322
12